BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35046233)

  • 1. [A CASE OF PRIMARY ADRENAL LYMPHOMA SUSPECTED AS ADRENAL METASTATIC TUMOR FROM GASTROINTESTINAL STROMAL TUMOR].
    Kanaki T; Kawashima A; Fukuhara S; Fujita K; Uemura M; Kiuchi H; Imamura R; Nonomura N
    Nihon Hinyokika Gakkai Zasshi; 2021; 112(1):29-33. PubMed ID: 35046233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
    Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
    [No Abstract]   [Full Text] [Related]  

  • 3. [A Case of Peritoneal Metastasis Resection from GIST of the Small Intestine with Focal Resistance Against Imatinib Mesylate].
    Ono T; Tanaka N; Suzuki H; Imoto H; Yamamura A; Karasawa H; Kohyama A; Aoki T; Watanabe K; Ohnuma S; Musha H; Motoi F; Kamei T; Naitoh T; Unno M
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2452-2454. PubMed ID: 32156962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal stromal tumor of the adrenal gland:a case report and review of the literature.
    Abou Al-Shaar H; Solimanie S; Azzam A; Amin T; Abu-Zaid A
    Endocr Pathol; 2015 Mar; 26(1):27-32. PubMed ID: 25510634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of imatinib trough concentration at steady state in adjuvant therapy of patients with high risk gastrointestinal stromal tumor].
    Wan WZ; Zhang P; Zeng XY; Zhou H; Lin Y; Xiong Z; Zhang RZ; Liu WZ; Han Y; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):848-855. PubMed ID: 31550824
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
    Choi H; Charnsangavej C; Faria SC; Macapinlac HA; Burgess MA; Patel SR; Chen LL; Podoloff DA; Benjamin RS
    J Clin Oncol; 2007 May; 25(13):1753-9. PubMed ID: 17470865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse large B-cell lymphoma solely involving bilateral adrenal glands and stomach: report of an extremely rare case with review of the literature.
    Wakabayashi M; Sekiguchi Y; Shimada A; Ichikawa K; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2014; 7(11):8190-7. PubMed ID: 25550871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of liver and bone metastasis from gastrointestinal stromal tumor treated using imatinib].
    Murakami M; Ebisui C; Okada K; Okamura S; Murata K; Nakagomi N; Tamai M; Kinuta M
    Gan To Kagaku Ryoho; 2014 Jan; 41(1):99-101. PubMed ID: 24423961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Long-Term Adjuvant Therapy With Imatinib Mesylate After Extensive Surgical Treatment for Ruptured Gastrointestinal Stromal Tumors of the Small Intestine With Peritoneal Metastases: A Case Report.
    Kimura T; Togawa T; Onishi K; Iida A; Sato Y; Goi T
    J Investig Med High Impact Case Rep; 2020; 8():2324709620970736. PubMed ID: 33228387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07).
    Montemurro M; Cioffi A; Dômont J; Rutkowski P; Roth AD; von Moos R; Inauen R; Toulmonde M; Burkhard RO; Knuesli C; Bauer S; Cassier P; Schwarb H; Le Cesne A; Koeberle D; Bärtschi D; Dietrich D; Biaggi C; Prior J; Leyvraz S
    Cancer; 2018 Apr; 124(7):1449-1454. PubMed ID: 29315500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to
    Van Weehaeghe D; Gheysens O; Vandecaveye V; Schöffski P; Van Laere K; Deroose CM
    BMC Cancer; 2018 Mar; 18(1):253. PubMed ID: 29506493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological complete response in advanced gastrointestinal stromal tumor after imatinib therapy.
    Melichar B; Voboril Z; Nozicka J; Ryska A; Urminská H; Vanecek T; Michal M
    Intern Med; 2005 Nov; 44(11):1163-8. PubMed ID: 16357454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous Large Gastrointestinal Stromal Tumor and Adenocarcinoma in the Stomach Treated with Imatinib Mesylate Followed by Total Gastrectomy.
    Namikawa T; Munekage E; Munekage M; Maeda M; Yatabe T; Kitagawa H; Sakamoto K; Obatake M; Kobayashi M; Hanazaki K
    Anticancer Res; 2016 Apr; 36(4):1855-9. PubMed ID: 27069170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT.
    Valls-Ferrusola E; García-Garzón JR; Ponce-López A; Soler-Peter M; Fuertes-Cabero S; Moragas-Solanes M; Riera-Gil E; Carrió-Gasset I; Lomeña-Caballero F
    Rev Esp Enferm Dig; 2012 Jul; 104(7):360-6. PubMed ID: 22849497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of metastatic gastrointestinal stromal tumor developing a resistance to STI571 (imatinib mesylate)].
    Miyake M; Takeda Y; Hasuike Y; Kashiwazaki M; Mishima H; Ikenaga M; Mano M; Takada Y; Hirota S; Tsujinaka T
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1791-4. PubMed ID: 15553717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Case of Surgical Resection of an Esophageal Gastrointestinal Stromal Tumor after Neoadjuvant Therapy with Imatinib].
    Nishida Y; Takeda S; Kanekiyo S; Shindo Y; Matsukuma S; Matsui H; Tokumitsu Y; Tomochika S; Iida M; Suzuki N; Yoshino S; Hazama S; Ueno T; Nagano H
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2449-2451. PubMed ID: 32156961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors.
    Keung EZ; Fairweather M; Raut CP
    Curr Treat Options Oncol; 2016 Feb; 17(2):8. PubMed ID: 26820287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice.
    Rutkowski P; Ziętek M; Cybulska-Stopa B; Streb J; Głuszek S; Jankowski M; Łopacka-Szatan K; Las-Jankowska M; Hudziec P; Klimczak A; Olesiński T; Świtaj T; Koseła-Paterczyk H; Bylina E; Osuch C
    Eur J Surg Oncol; 2021 May; 47(5):1191-1195. PubMed ID: 32826113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preoperative Imatinib Therapy Followed by Laparoscopic Local Gastrectomy for a Giant Gastric Gastrointestinal Stromal Tumor-A Case Report].
    Inukai M; Shibasaki S; Suzuki K; Tsuru Y; Matsuo K; Goto A; Nakamura K; Tanaka T; Kikuchi K; Suda K; Inaba K; Uyama I
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2062-2064. PubMed ID: 33468801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.